Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2008
06/19/2008WO2008072713A1 Method of estimating secondary structure in rna and program and apparatus therefor
06/19/2008WO2008072640A1 A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED EXPRESSION OF ANY OF THE cynT, cynS, cynX OR cynR GENE OR COMBINATION THEREOF
06/19/2008WO2008072547A1 Promoter and expression vector for actinomycetes
06/19/2008WO2008072540A1 Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME
06/19/2008WO2008072075A2 Transferrin fusion protein libraries
06/19/2008WO2008071973A1 Selection method
06/19/2008WO2008071959A1 Lentiviral vectors comprising micrornas
06/19/2008WO2008071934A1 Treatment of cachexia
06/19/2008WO2008071771A2 Inhibition of gpr4
06/19/2008WO2008071767A1 Plants having enhanced seed yield-related traits and a method for making the same
06/19/2008WO2008071755A2 Casein-derived peptides having anxiolytic activity
06/19/2008WO2008071751A1 Delivery of binding molecules to induce immunomodulation
06/19/2008WO2008071726A2 Pathogen inducible plant trehalose-6-phophate phophatase gene promoters and regulatory elements
06/19/2008WO2008071715A1 Herbicide-resistant sunflower plants and methods of use
06/19/2008WO2008071430A1 Transfection microarrays
06/19/2008WO2008071385A2 Use of acetals for the isolation of nucleic acids
06/19/2008WO2008071384A1 Use of tde for the isolation of nucleic acids
06/19/2008WO2008071093A1 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10
06/19/2008WO2008071081A1 Preparation of low bleeding anticoagulant fusion protein and its use
06/19/2008WO2008070927A1 Multimeric fc receptor polypeptides including a modified fc domain
06/19/2008WO2008055069A3 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine
06/19/2008WO2008054747A3 Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
06/19/2008WO2008053487A3 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
06/19/2008WO2008052991A3 Butanol production in a eukaryotic cell
06/19/2008WO2008052797A3 Expression vectors for multiple gene integration and overexpression of homologous and heterologous proteins in yeasts of the genus arxula
06/19/2008WO2008051854A9 A tunable genetic switch for regulating gene expression
06/19/2008WO2008047227A3 Method of assaying hiv-1 tropism for ccr5 and/or cxcr4 co-receptor and/or susceptibility to entry inhibitors
06/19/2008WO2008046189A9 Proteins involved in after-cooking darkening in potatoes
06/19/2008WO2008043777B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers
06/19/2008WO2008041107A3 Fluorescent proteins from the ctenophora phylum and methods of use thereof
06/19/2008WO2008028115A3 Methods for producing transgenic plants
06/19/2008WO2008012682A3 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
06/19/2008WO2007147029A3 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use
06/19/2008WO2007141705A3 Plant promoters
06/19/2008WO2007137300A3 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
06/19/2008WO2007131495A3 Multimer for immunostimulation
06/19/2008WO2007117282A3 Lactic acid-producing yeast cells having nonfunctional l-or d-lactate: ferricytochrome c oxidoreductase gene
06/19/2008WO2007106424A3 Treating cancers with activated ras through inhibition of pkc delta
06/19/2008WO2007100897A3 Energy crops for improved biofuel feedstocks
06/19/2008WO2001034766A3 Protein monitoring the activity of small gtp-binding protein
06/19/2008US20080148434 Plant Fatty Acid Synthases and Use in Improved Methods for Production of Medium-Chain Fatty Acids
06/19/2008US20080148433 Expression vector comprising nucleotide sequences coding malonyl-CoA:ACP acyltransferase (MAT), beta -keto acyl-ACP synthase (KS) and ketoreductase (KR) for transforming and propagating cells with enhanced concentrations of polyunsaturated fatty acid (PUFA)
06/19/2008US20080148432 Recombinant cell for use in propagation of freeze and drought resistant plants with enhanced oil and seed protein production
06/19/2008US20080148431 Herbicide resistant picea comprising expression vector coding prephenate dehydrogenase for use as bioreactor for synthesis of tyrosine
06/19/2008US20080148430 Using transgenic plants as bioreactor for measuring or detecting mitogen-activated protein (MAP) kinase activity
06/19/2008US20080148429 Mitochondrial DNA sequences for use as diagnostic indicator of plants manifesting cytoplasmic male sterile phenotypes
06/19/2008US20080148428 Transgenic crop plant for propagating herbicide tolerant, insect, pest and/or disease resistant plants with enhanced fatty acid and carbohydrate metabolism
06/19/2008US20080148421 Transgenic seeds for use in propagation of disease, herbicide and insect resistant plants with enhanced carbohydrate and fatty acid metabolism
06/19/2008US20080148420 Transgenic seeds for use in propagation of disease, herbicide and insect resistant plants with enhanced carbohydrate and fatty acid metabolism
06/19/2008US20080148417 Rodent animal model comprising mutation in colinergic receptor nicotinic alpha-4 (CHRNA4) gene for use in identifying modulator for prevention and treatment of seizure disorders
06/19/2008US20080148416 Animal models for monitoring activity of drug metabolizing enzymes; side effect reduction; assessing xenobiotics
06/19/2008US20080146791 Solid support comprising immobilized receptors for use in isolating preferential nucleotide sequences in solution
06/19/2008US20080146788 has a plurality of modified ribofuranosyl nucleosides at defined locations; comprise double stranded constructs wherein one of the strands capable of hybridizing to a nucleic acid target
06/19/2008US20080146785 Antibody against tumor specific antigen as target
06/19/2008US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering
06/19/2008US20080146518 Cationic Lipids for the Transfection of Nucleic Acids
06/19/2008US20080146507 Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
06/19/2008US20080146505 47 Human Secreted Proteins
06/19/2008US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
06/19/2008US20080146495 methods for inhibiting the ability of HIV genes products to bind to the cytoplasmic domain of a CD4 receptor. This domain is necessary to the ability of the HIV Nef and Vpu gene products to connect the CD4 receptor to cellular degradation pathways.
06/19/2008US20080146492 Insulin production methods and pro-insulin constructs
06/19/2008US20080146461 Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
06/19/2008US20080146460 Optical probes and assays
06/19/2008US20080146459 Protein Array and Process for Producing the Same
06/19/2008US20080146447 Applying to crop plants and weeds a pyruvic acid dioxygenase inhibitor to control weeds without affecting the growth
06/19/2008US20080145943 Cng2b: a novel human cyclic nucleotide-gated ion channel
06/19/2008US20080145938 Buffer solution for electroporation and a method comprising the use of the same
06/19/2008US20080145937 In Vivo Transformation of Pancreatic Acinar Cells into Insulin-Producing Cells
06/19/2008US20080145936 Control of ES Cell Self Renewal and Lineage Specification, and Medium Therefor
06/19/2008US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
06/19/2008US20080145928 Nucleotide sequences coding transcription factor for use in prevention and treatment of cell proliferative disorders
06/19/2008US20080145927 Stresscopins and their uses
06/19/2008US20080145916 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
06/19/2008US20080145915 Hepatitis C virus vaccine
06/19/2008US20080145913 Endonuclease which reasserts mutations between related polynucleotides via formation of heteroduplex molecules and then addressing mismatches
06/19/2008US20080145912 Cellulytic enzyme for use in paper making, textile treatment and laundry detergents
06/19/2008US20080145897 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, Isolated PEF protein, and methods for purifying and identifying
06/19/2008US20080145896 Anti Hiv-I Bacterial and Baculovirus Recombinant Epap-1
06/19/2008US20080145895 Expression vector comprising nucleotide sequences coding light and heavy chain immunoglobulin segments for use as efficient gene transfer element in genetic engineering and gene therapy
06/19/2008US20080145893 Using chineese hamster ovaries as bioreactors for biosynthesis of immunoglobulin lihgt and heavy chains
06/19/2008US20080145892 Expression vector comprising DBV gene cluster for use in transformation and synthesis of preferential peptide antibiotic
06/19/2008US20080145889 Using pancreatic inslet stem cell as drug testing models; tissue engineering and regenerative medicine
06/19/2008US20080145888 Assessment method
06/19/2008US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use
06/19/2008US20080145866 Modified human thymic stromal lymphopoietin
06/19/2008US20080145865 Assays for rab5 activity
06/19/2008US20080145860 Encapsulated cell indicator system
06/19/2008US20080145859 Diagnosis and treatment of cancer
06/19/2008US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis
06/19/2008US20080145839 Method and Nucleic Acids For the Differentiation of Astrocytoma, Oligoastrocytoma and Oligodenroglioma Tumor Cells
06/19/2008US20080145413 Lipids and lipid assemblies comprising transfection enhancer elements
06/19/2008US20080145381 Multi-subtype FIV vaccines
06/19/2008US20080145379 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
06/19/2008US20080145377 G-CSF Polypeptides And Uses Thereof
06/19/2008US20080145376 Vectors And Methods For Genetic Immunization
06/19/2008US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents
06/19/2008US20080145365 Human and mammalian stem cell-derived neuron survival factors
06/19/2008US20080145362 Antibody combination useful for tumor therapy
06/19/2008US20080145359 Imaging, diagnosis and treatment of disease
06/19/2008US20080145353 Perhydrolase